Subscribe
Home Economics Jim Grant: Biotech Most Worrisome Portion Of Stock Market

Jim Grant: Biotech Most Worrisome Portion Of Stock Market

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.

“The Fed has its thumb on the scales of our finances,” says Jim Grant of Grant’s Interest Rate Observer, weighing in on Janet Yellen and the Fed’s interest rate policy.

H/T Value investing

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Sheeraz Raza
Editor

Related news

Inflation Rate
PCE Inflation Rises to 2.3% in October, But December Rate Cut Still Expected
Dave Kovaleski
Vanguard 2025 Outlook: U.S. Stocks Can “Defy Their Valuation Gravity” 
Dave Kovaleski
Consumer Price Index CPI
CPI Inflation Rate Climbs to 2.6% in October
Dave Kovaleski
FOMC Lowers Rates by 25 Points, Won’t “Speculate” or “Assume” on Trump Policies
Dave Kovaleski
PCE Inflation Falls to 2.1% in September, Near Fed’s Target of 2%
Dave Kovaleski

Must Read

New

How to Invest in Stocks in 2024 – Beginner’s Guide

Investing in stocks can be a great way to improve your overall wealth – but...

23 Min Read Read now

Latest News

5g technology
Frequently Asked Questions

Embrace Dogecoin with Utility with the Doge² Upgrade – Best Crypto to Buy?
Eric Dunne3 hours

Dogecoin has historically been a project associated with jokes. While those evolved into more profound charitable initiatives, no formidable use case could be developed due to the shortfalls of the...

Categories

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.